Conferences

The Schroeder Institute’s state-of-the-science conference series identifies extraordinary opportunities in basic science, intervention, and policy on tobacco use behavior with the potential to dramatically improve the nation’s health. The series stimulates the field to focus on “what we know and what we need to know that will make a difference.” The series is a call to action to highlight recommendations for research focus and investment by funding agencies. The ultimate goal is to alert the science, practice, and policy communities to the most pressing and exciting opportunities and challenges that will improve the nation’s health and well-being.

Online Social Networks and Smoking Cessation (OSNSC)

The Schroeder Institute’s state-of-the-science conference series identifies extraordinary opportunities in basic science, intervention, and policy on tobacco use behavior with the potential to dramatically improve the nation’s health. The series stimulates the field to focus on “what we know and what we need to know that will make a difference.” The series is a call to action to highlight recommendations for research focus and investment by funding agencies. The ultimate goal is to alert the science, practice, and policy communities to the most pressing and exciting opportunities and challenges that will improve the nation’s health and well-being.

FDA Consensus Conference

On November 30th and December 1st, 2009, the Schroeder Institute convened a two-day meeting in Washington, D.C. titled Research Strategies to Inform FDA Regulation of Tobacco Products to begin an unprecedented deliberation of the extraordinary opportunity and pressing challenges to maximizing the FDA regulation of tobacco. Led by Dr. David Abrams (SI) and Mitch Zeller (Pinney Associates), the purpose of the meeting was to discuss how a strategic science base could best inform, support, protect, and evaluate FDA actions related to the regulation of tobacco for the benefit of public health.